The US Neonatal Intensive Care Market growth continues to thrive as regenerative medicine and stem cell therapies open new therapeutic frontiers. With preterm infants experiencing complications that traditional medicine cannot fully address, researchers are exploring mesenchymal stem cell therapies for bronchopulmonary dysplasia and necrotizing enterocolitis. Growing investments in placental...